John Glenn Ekso Bionics Holdings, Inc. (EKSO) insider trading activity

EKSO Quotes by TradingView

John Glenn is Chief Financial Officer of EKSO BIONICS HOLDINGS, INC.. Currently has a direct ownership of 35,130 shares of EKSO, which is worth approximately $24,239. The most recent transaction as insider was on Mar 22, 2022, when has been sold 3,462 shares (Common Stock) at a price of $2.82 per share, resulting in proceeds of $9,763. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.1K
0% 3M change
0% 12M change
Total Value Held $24,239

JOHN GLENN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 22 2022
SELL
Open market or private sale
$9,763 $2.82 p/Share
3,462 Reduced 8.97%
35,130 Common Stock
Feb 17 2022
BUY
Grant, award, or other acquisition
-
14,596 Added 27.44%
38,592 Common Stock
Mar 03 2021
BUY
Grant, award, or other acquisition
-
13,015 Added 35.17%
23,996 Common Stock

Also insider at

IRMD
IRADIMED CORP Healthcare
CHIEF FINANCIAL OFFICER
JG

John Glenn

Chief Financial Officer
Richmond, CA

Track Institutional and Insider Activities on EKSO

Follow EKSO BIONICS HOLDINGS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EKSO shares.

Notify only if

Insider Trading

Get notified when an Ekso Bionics Holdings, Inc. insider buys or sells EKSO shares.

Notify only if

News

Receive news related to EKSO BIONICS HOLDINGS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EKSO